Talk:List of investigational hallucinogens and entactogens
Appearance
This is the talk page for discussing improvements to the List of investigational hallucinogens and entactogens article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated List-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||
|
MDMA under both undeveloped and developing drugs.
[edit]MDMA is in both of these sections despite this being a list. 172.56.164.121 (talk) 12:43, 8 November 2024 (UTC)
- There is a one list entry per investigational new drug program. So a single drug can be developed independently by multiple different pharmaceutical companies and thus have multiple entries in the list. MDMA is being developed independently by five different pharmaceutical companies. It's being developed by these countries for different indications and for use by different routes of administration. And each is in different developmental phases. That's why MDMA is listed multiple times. (R)-MDMA is being developed independently by two different pharmaceutical companies also. – 76.174.0.57 (talk) 06:05, 10 November 2024 (UTC)
Categories:
- List-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- List-Class medicine articles
- Low-importance medicine articles
- List-Class neurology articles
- Mid-importance neurology articles
- Neurology task force articles
- All WikiProject Medicine pages
- List-Class List articles
- Unknown-importance List articles
- WikiProject Lists articles